ZAZO: Zinc Sulphate vs. Zinc Amino Acid Chelate
Study Details
Study Description
Brief Summary
Acute respiratory infection and acute diarrhea are among the most prevalent diseases of childhood increase the burden of morbidity and mortality in children under 5 years.
Among the possible strategies for its prevention is important to count on good nutritional status for use in developing a good immune response to infections. Zinc deficiency has been shown to favor the development of infections and has been considered a real public health problem.
Within the zinc compounds used are zinc amino acid chelate and zinc sulphate, the first that has shown evidence of being better absorbed and tolerated.
We propose a study showing the effectiveness of zinc amino acid chelate and zinc sulphate in the prevention of acute diarrheal disease and acute respiratory infection.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Zinc sulphate Preschool children healthy enrolled in FAN Foundation of Medellin, which will be supplied with zinc sulphate |
Dietary Supplement: Zinc sulfate as dietary supplementation
Zinc sulfate as dietary supplementation
|
Experimental: Zinc Amino Acid Chelate Preschool children healthy enrolled in FAN Foundation of Medellin , which will be supplied with zinc amino acid chelate |
Dietary Supplement: Zinc amino acid chelate as dietary supplementation
Zinc amino acid chelate as dietary supplementation
|
Placebo Comparator: Milk without fortification Milk without zinc |
Dietary Supplement: Milk without fortification without zinc
Milk without fortification
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Incidence acute diarrheal disease and acute respiratory infection [Up to 16 weeks]
Preschool children will drink fortified milk with zinc amino acid chelate, zinc sulfate or milk without fortification. Fortnightly monitoring will be investigating the presence of infection (acute diarrheal disease and respiratory infections). Supervision and monitoring will be carried out for four months.
Secondary Outcome Measures
- Adverse reaction [Fortnightly. During 4 months of intervention]
The caregiver recorded daily if the child had an adverse reaction such as abdominal pain, nausea and vomiting.
Eligibility Criteria
Criteria
Inclusion Criteria:
Children who
-
Belong to institute FAN in Medellín
-
Attend full time to institute FAN (eight hours)
-
Have 2 to 5 years
Exclusion Criteria:
Children who
-
Children at the began of the study are with acute diarrheal disease and acute respiratory infection.
-
Recurrent pneumonia, cystic fibrosis, gastrointestinal malformations, persistent diarrhea of any cause, inflammatory bowel disease.
-
Failure to attend the educational institution for more than 10 days
-
No consumption of zinc supplementation for more than 10 days, because of insistence to the school
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | CES University | Medellín | Antioquia | Colombia |
Sponsors and Collaborators
- CES University
- Nutreva S.A.S.
- Foundation Child Care - FAN
Investigators
- Study Director: Liliana LM Montoya, Master, CES University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ZAZO-01